FI971081A - Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina - Google Patents

Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina Download PDF

Info

Publication number
FI971081A
FI971081A FI971081A FI971081A FI971081A FI 971081 A FI971081 A FI 971081A FI 971081 A FI971081 A FI 971081A FI 971081 A FI971081 A FI 971081A FI 971081 A FI971081 A FI 971081A
Authority
FI
Finland
Prior art keywords
alkyl
triazolopyridazines
intermediates
preparation
medicinal substances
Prior art date
Application number
FI971081A
Other languages
English (en)
Swedish (sv)
Other versions
FI971081A0 (fi
Inventor
Yasuhiko Kawano
Akio Miyake
Yasuko Ashida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/306,423 external-priority patent/US5482939A/en
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI971081A0 publication Critical patent/FI971081A0/fi
Publication of FI971081A publication Critical patent/FI971081A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI971081A 1994-09-16 1997-03-14 Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina FI971081A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/306,423 US5482939A (en) 1992-03-18 1994-09-16 Triazolopyridazine compounds, their production and use
JP22748194 1994-09-22
PCT/JP1995/001797 WO1996008496A1 (en) 1994-09-16 1995-09-11 Triazolopyridazines process and intermediates for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
FI971081A0 FI971081A0 (fi) 1997-03-14
FI971081A true FI971081A (fi) 1997-05-06

Family

ID=26527697

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971081A FI971081A (fi) 1994-09-16 1997-03-14 Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina

Country Status (13)

Country Link
EP (1) EP0781283B1 (fi)
KR (1) KR970706287A (fi)
CN (1) CN1046517C (fi)
AT (1) ATE201875T1 (fi)
AU (1) AU695377B2 (fi)
CA (1) CA2198019A1 (fi)
DE (1) DE69521209T2 (fi)
FI (1) FI971081A (fi)
HU (1) HUT77130A (fi)
NO (1) NO308003B1 (fi)
NZ (1) NZ292271A (fi)
RU (1) RU2156252C2 (fi)
WO (1) WO1996008496A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7079998A (en) 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Condensed pyridazine derivatives, their production and use
AU3274199A (en) * 1998-03-04 1999-09-20 Takeda Chemical Industries Ltd. Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
WO1999049865A1 (en) * 1998-03-31 1999-10-07 Mayo Foundation For Medical Education And Research Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation
CA2346659A1 (en) 1998-10-06 2000-04-13 Michiyo Gyoten Condensed pyridazine compounds, their production and use
US6627630B1 (en) 1998-10-21 2003-09-30 Takeda Chemical Industries, Ltd. Condensed pyridazine derivatives, their production and use
WO2001021177A1 (fr) * 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Inhibiteurs d'expression de chemokine/cytokine
BRPI0514586A (pt) * 2004-09-02 2008-06-17 Altana Pharma Ag triazolftalazinas
WO2009097970A1 (de) * 2008-02-05 2009-08-13 Sanofi-Aventis Triazolopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
KR20100120139A (ko) * 2008-02-05 2010-11-12 사노피-아벤티스 Par1 억제제로서의 트리아졸륨 염, 이들의 제조방법, 및 약제로서의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW211013B (fi) * 1991-12-27 1993-08-11 Takeda Pharm Industry Co Ltd
LT3200B (en) * 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
TW304878B (fi) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
AU695377B2 (en) 1998-08-13
ATE201875T1 (de) 2001-06-15
CN1158130A (zh) 1997-08-27
KR970706287A (ko) 1997-11-03
EP0781283B1 (en) 2001-06-06
CA2198019A1 (en) 1996-03-21
AU3399995A (en) 1996-03-29
NO308003B1 (no) 2000-07-03
WO1996008496A1 (en) 1996-03-21
DE69521209T2 (de) 2002-03-07
FI971081A0 (fi) 1997-03-14
RU2156252C2 (ru) 2000-09-20
DE69521209D1 (de) 2001-07-12
HUT77130A (hu) 1998-03-02
CN1046517C (zh) 1999-11-17
NO971117L (no) 1997-03-11
NO971117D0 (no) 1997-03-11
NZ292271A (en) 1998-04-27
EP0781283A1 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
ES8801651A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isozazoles y furanos
IE883463L (en) 3-£4(1-Substituted-4-piperazinyl)butyl|-4-thiazolidinones, a process for their preparation and their use as medicaments
FI971081A0 (fi) Triatsolopyridatsiinit, menetelmä ja välituotteet niiden valmistamiseksi sekä niiden käyttö lääkeaineina
ES8608524A1 (es) Procedimiento para preparar 5h, 11h-pirrolo (2, 1-c)-(1, 4) benzoxazepinas sustituidas en posicion 11
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
EP0362942A3 (en) Benzoxazepinone process
ES8406998A1 (es) Procedimiento para la obtencion de fenoxipropionatos sustituidos.
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
PT80746B (en) Pyrrolo<1,2-b> <1,2,5>triazepines a process and intermediates for their preparation and their use as medicaments
AU547599B2 (en) Tricyclic compounds
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
ES8506313A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo(3.2.0)hepteno.
CA2272136A1 (en) Pyrazole derivatives having crf antagonist activity
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.